- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06110689
Capturing Physiologic Autonomic Data from Clinically Indicated Magnetic Resonance Imaging Scans in Children (CMRI)
The Fontan Procedure is a palliative surgical procedure used in pediatric patients with one functional ventricle. The procedure, a series of stepwise operations that alter cardiorespiratory physiology, separate the systemic and pulmonary circulations to create Fontan physiology, where the systemic venous blood flows passively and without ventricular thrust into the pulmonary circulation. The hallmark of the Fontan circulation is a sustained, abnormally elevated central venous pressure combined with decreased cardiac output, especially during periods of increased demands. Results of several studies in Fontan patients have shown reduced parasympathetic and sympathetic activity compared to controls. In children with congenital heart disease, a differential diagnosis of autonomic dysfunction may be part of their pathophysiology, a compensatory mechanism, a consequence of surgical procedures or a combination of these.
In children, measurement of ANS function is equally important. Children with single ventricle physiology (and other cardiac conditions) have routine surveillance and cardiac magnetic resonance (CMR) imaging to monitor for disease progression. While autonomic data is routinely collected and is available from these scans, these data are rarely, collected and analyzed; however, our group has shown feasibility. Therefore, autonomic data is usually unavailable in children. Despite the availability of agerelated normal values, the predictive power of autonomic activity is understudied in children and there are no published studies of quantification of autonomic data in this population.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Ages 0 to ≤ 30 years
- Baseline sinus rhythm (interventricular conduction delays and bundle branch blocks allowed); and undergoing CMR scan in which sequences containing timing of aortic valve opening (cine), vector cardiogram (VCG) and respiratory bellows use will be obtained
- Fontan physiology - only for the Fontan group. Chest wall deformity or arrhythmogenic right ventricular cardiomyopathy for the healthy control group
Exclusion Criteria:
- Patient or family refusal;
- Contraindication to study procedures
- Prior participation in the study (ie, we plan to sample without replacement)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Fontan
Patients undergoing cardiac MRI for Fontan,
|
Patients will wear the VU-AMS monitor prior to MRI.
|
|
Healthy controls
Patients undergoing thoracic MRI for chest wall deformity.
|
Patients will wear the VU-AMS monitor prior to MRI.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
80% availability of respiratory sinus arrhythmia from cardiac MRI (magnetic resonance imaging)
Time Frame: Through MRI completion up to one hour
|
Data collected during MRI
|
Through MRI completion up to one hour
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare estimate of pre-ejection period (PEP)
Time Frame: Prior to MRI scan up to 10 minutes
|
Collection of data from VU-AMS monitor
|
Prior to MRI scan up to 10 minutes
|
|
Compare estimate of pre-ejection period (PEP)
Time Frame: Through MRI completion up to one hour
|
Collection of data from the cardiac MRI
|
Through MRI completion up to one hour
|
|
Describe difference in respiratory sinus arrhythmia in participants with Fontan
Time Frame: Through MRI completion up to one hour
|
Collection of data from the cardiac MRI
|
Through MRI completion up to one hour
|
|
Describe difference in respiratory sinus arrhythmia in participants with pectus
Time Frame: Through MRI completion up to one hour
|
Collection of data from the cardiac MRI
|
Through MRI completion up to one hour
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pornswan Ngamprasertwong, MD, Children's Hospital Medical Center, Cincinnati
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-0400
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Anomaly
-
Christopher BreuerGunze Limited; Doris Duke Charitable FoundationCompletedSingle Ventricle Cardiac AnomalyUnited States
-
GLYCAR SA (Pty) LtdCompletedCardiac Anomaly | Cardiac Defect | Pericardial DefectSouth Africa
-
University Hospital, GhentRecruitingMullerian Anomaly of Uterus, Nec | Mullerian Anomaly of Vagina | Mullerian Anomaly of CervixBelgium
-
University of California, San DiegoWithdrawnMajor Fetal AnomalyUnited States
-
University Hospital, GhentRecruitingMullerian Anomaly of Uterus, Nec | Mullerian Anomaly of Vagina | Mullerian Anomaly of CervixBelgium
-
Hospital Universitario Dr. Jose E. GonzalezRecruitingGestational Diabetes | Fetal Cardiac AnomalyMexico
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaTerminated
-
Sohag UniversityNot yet recruiting
-
Artivion Inc.TerminatedCongenital Heart Disease | Cardiac AnomalyUnited States
-
Samuel Lunenfeld Research Institute, Mount Sinai...WithdrawnPsychological Sequelae of Termination of Pregnancy for Fetal AnomalyCanada
Clinical Trials on VU-AMS device
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Boston Scientific CorporationCompletedErectile Dysfunction | ImpotenceUnited States, Canada
-
The Cleveland ClinicMotus GI Medical Technologies LtdTerminatedLower Gastrointestinal Bleeding | Hemostatic DisorderUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); Perceptive Navigation LLCWithdrawnVascular AccessUnited States
-
Boston Scientific CorporationCompletedStress Urinary IncontinenceBelgium, France
-
ASTORA Women's HealthCompletedPelvic Organ ProlapseUnited States, Belgium, France, Germany, Netherlands, Spain, United Kingdom
-
Luxembourg Institute of HealthCentre Hospitalier du Luxembourg; Luxembourg National Research Fund (FNR); Meracle...RecruitingAsthma | Inhalation Spacers | Asthma ChildhoodLuxembourg
-
American Medical SystemsCompletedErectile DysfunctionUnited States
-
Motus GI Medical Technologies LtdTerminated
-
University of MinnesotaCompleted